Literature DB >> 22772541

New biomarkers sought for improving sepsis management and care.

Melinda Wenner Moyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22772541     DOI： 10.1038/nm0712-999

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  2 in total

1.  Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis.

Authors:  Athina Savva; Maria Raftogiannis; Fotini Baziaka; Christina Routsi; Anastasia Antonopoulou; Pantelis Koutoukas; Thomas Tsaganos; Anastasia Kotanidou; Efterpi Apostolidou; Evangelos J Giamarellos-Bourboulis; George Dimopoulos
Journal:  J Infect       Date:  2011-08-03       Impact factor: 6.072

2.  Measurement of plasma sTREM-1 in patients with severe sepsis receiving early goal-directed therapy and evaluation of its usefulness.

Authors:  Su Jin Jeong; Young Goo Song; Chang Oh Kim; Hye Won Kim; Nam Su Ku; Sang Hoon Han; Jun Yong Choi; June Myung Kim
Journal:  Shock       Date:  2012-06       Impact factor: 3.454
  2 in total
  16 in total

1.  Biomarkers in sepsis.

Authors:  Keith R Walley
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

2.  Molecular diagnosis of sepsis: New aspects and recent developments.

Authors:  O Liesenfeld; L Lehman; K-P Hunfeld; G Kost
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-03-14

3.  Double blockade of CD14 and complement C5 abolishes the cytokine storm and improves morbidity and survival in polymicrobial sepsis in mice.

Authors:  Markus Huber-Lang; Andreas Barratt-Due; Søren E Pischke; Øystein Sandanger; Per H Nilsson; Miles A Nunn; Stephanie Denk; Wilhelm Gaus; Terje Espevik; Tom E Mollnes
Journal:  J Immunol       Date:  2014-04-30       Impact factor: 5.422

4.  Small bowel volvulus in mid and late pregnancy: can early diagnosis be established to avoid catastrophic outcomes?

Authors:  Qing Cong; Xilian Li; Xuping Ye; Li Sun; Wei Jiang; Zhigang Han; Weiqi Lu; Huan Xu
Journal:  Int J Clin Exp Med       Date:  2014-11-15

5.  Diagnostic Accuracy of Cerebrospinal Fluid Procalcitonin in Bacterial Meningitis Patients with Empiric Antibiotic Pretreatment.

Authors:  Wen Li; Xiaolong Sun; Fang Yuan; Qiong Gao; Yue Ma; Yongli Jiang; Xiai Yang; Fang Yang; Lei Ma; Wen Jiang
Journal:  J Clin Microbiol       Date:  2017-02-08       Impact factor: 5.948

6.  Predictive values of the SOFA score and procalcitonin for septic shock after percutaneous nephrolithotomy.

Authors:  Haifeng Hou; Jun Yang; Zhenhua Han; Xiaoyang Zhang; Xiaoying Tang; Tianming Chen
Journal:  Urolithiasis       Date:  2022-10-10       Impact factor: 2.861

7.  Procalcitonin as an early diagnostic and monitoring tool in urosepsis following percutaneous nephrolithotomy.

Authors:  Ji Zheng; Qianwei Li; Weihua Fu; Jing Ren; Siji Song; Guoxian Deng; Jiwei Yao; Yongquan Wang; Weibing Li; Junan Yan
Journal:  Urolithiasis       Date:  2014-09-07       Impact factor: 3.436

Review 8.  Use of early biomarkers in neonatal brain damage and sepsis: state of the art and future perspectives.

Authors:  Iliana Bersani; Cinzia Auriti; Maria Paola Ronchetti; Giusi Prencipe; Diego Gazzolo; Andrea Dotta
Journal:  Biomed Res Int       Date:  2015-01-18       Impact factor: 3.411

9.  A high angiopoietin-2/angiopoietin-1 ratio is associated with a high risk of septic shock in patients with febrile neutropenia.

Authors:  Maiara Marx Luz Fiusa; Carolina Costa-Lima; Gleice Regina de Souza; Afonso Celso Vigorito; Francisco Jose Penteado Aranha; Irene Lorand-Metze; Joyce M Annichino-Bizzacchi; Carmino Antonio de Souza; Erich V De Paula
Journal:  Crit Care       Date:  2013-08-05       Impact factor: 9.097

10.  MyD88-, but not Nod1- and/or Nod2-deficient mice, show increased susceptibility to polymicrobial sepsis due to impaired local inflammatory response.

Authors:  Fabiane Sônego; Fernanda V S Castanheira; Paula G Czaikoski; Alexandre Kanashiro; Fabricio O Souto; Rafael O França; Daniele C Nascimento; Andressa Freitas; Fernando Spiller; Larissa D Cunha; Dario S Zamboni; José C Alves-Filho; Fernando Q Cunha
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.